Integrating GLP-1 Inhibitors into a Comprehensive Diabetes Care Management Regimen – The Incretin Experience Part 2

Integrating GLP-1 Inhibitors into a Comprehensive Diabetes Care Management Regimen – The Incretin Experience Part 2

A continuing discussion about integrating GLP-1 Inhibitors into diabetes care management from the 2015 National Medical Association Scientific Assembly, Family Medicine Section held August 3rd in Detroit, Michigan. This activity is intended for primary care and family medicine physicians, endocrinologists, internists, nurse practitioners, and other healthcare professionals interested in diabetes.

 

 


Published

February 1, 2017

Created by

National Medical Association